One of the main focuses in pulmonology is the search for new opportunities to improve the effectiveness of treatment and quality of life for patients with bronchial asthma and chronic obstructive pulmonary disease (COPD). Both of these diseases are not only incurable, but also poorly controlled, and, accordingly, require special attention. YURiA-PHARM specialists are trying to better understand all the links in the pathogenesis of these diseases and find ways to influence them. First of all, to provide comprehensive solutions for patients with severe asthma and COPD. It is these categories of patients that need a specialized approach to treatment.

We offer patients and doctors a full range of solutions for nebulizer therapy – inhalation devices (nebulizers), medicines for use through a nebulizer, as well as a wide range of accessories for nebulizers (masks, destroyers, nebulizer chambers, etc.).

Today, we are researching both the capabilities of existing drugs and the search and development of new drugs, combinations, and improving methods of their delivery. One of the most promising areas of development is modern inhalation delivery methods, in particular, dry powder inhalation devices (DPIs). They will significantly increase the effectiveness of treatment, its comfort and significantly reduce the cost of therapy for both patients and the healthcare system.